Samsara Bio Capital, LLC Novavax Inc Transaction History

Samsara Bio Capital, LLC

  • $194 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$5.76 - $12.48 $122,365 - $265,125
21,244 New
21,244 $147,000
Q2 2022

Aug 15, 2022
SELL
$36.28 - $75.29 $214,052 - $444,211
-5,900 Reduced 21.74%
21,244 $1.09 Million
Q4 2021

Feb 14, 2022
SELL
$134.56 - $217.97 $405,832 - $657,397
-3,016 Reduced 10.0%
27,144 $3.88 Million
Q4 2020

Feb 17, 2021
BUY
$78.74 - $139.5 $669,290 - $1.19 Million
8,500 Added 39.24%
30,160 $3.36 Million
Q3 2020

Nov 16, 2020
BUY
$79.44 - $178.51 $1.72 Million - $3.87 Million
21,660 New
21,660 $2.35 Million

Others Institutions Holding NVAX

# of Institutions
284
Shares Held
84.8M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email